{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Surgical Ablation for Atrial Fibrillation"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised controlled trial was conducted in Brazil, enrolling patients with symptomatic AF refractory to antiarrhythmic drugs or catheter ablation."
      },
      "Participants": {
        "score": 2,
        "evidence": "enrolling patients with symptomatic AF refractory to antiarrhythmic drugs or catheter ablation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either the Cox-Maze IV procedure with LAA occlusion or standard medical therapy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy of the Cox-Maze IV procedure and left atrial appendage (LAA) occlusion in patients with AF."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was freedom from AF at 12 months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In the intervention group, 98 participants were analysed using an intention-to-treat approach, while 97 were analysed in the control group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a 92% AF freedom rate at 12 months compared to 0% in the control group (p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included renal dysfunction and pacemaker requirement in <5% of the intervention group, with no increase in overall mortality."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Supported by Brazilian Ministry of Health."
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}